Ling Gu

1.8k total citations
57 papers, 1.4k citations indexed

About

Ling Gu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ling Gu has authored 57 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 21 papers in Cancer Research and 17 papers in Oncology. Recurrent topics in Ling Gu's work include PI3K/AKT/mTOR signaling in cancer (6 papers), Cancer-related Molecular Pathways (6 papers) and Cancer-related molecular mechanisms research (6 papers). Ling Gu is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (6 papers), Cancer-related Molecular Pathways (6 papers) and Cancer-related molecular mechanisms research (6 papers). Ling Gu collaborates with scholars based in China, United States and Denmark. Ling Gu's co-authors include Stephen A. Murray, Hongwu Zheng, Zhi-Xiong Jim Xiao, Xiaoou Tang, Xiao Zhen Zhou, Takafumi Uchida, Kun Ping Lu, Gerburg M. Wulf, Han You and Zhigui Ma and has published in prestigious journals such as Nature, Blood and PLoS ONE.

In The Last Decade

Ling Gu

53 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Gu China 22 1.0k 485 395 202 99 57 1.4k
Adriana Aguilar‐Mahecha Canada 19 835 0.8× 637 1.3× 420 1.1× 213 1.1× 61 0.6× 43 1.7k
V. Poulaki United States 17 735 0.7× 291 0.6× 300 0.8× 197 1.0× 69 0.7× 34 1.3k
Yan Jin China 23 773 0.7× 309 0.6× 262 0.7× 219 1.1× 59 0.6× 74 1.3k
Raphael B. Parmigiani Brazil 17 1.6k 1.5× 222 0.5× 459 1.2× 135 0.7× 91 0.9× 23 2.0k
Andrew Chantry United Kingdom 24 1.4k 1.3× 326 0.7× 415 1.1× 105 0.5× 70 0.7× 43 1.9k
Qihuang Jin China 17 1.8k 1.7× 313 0.6× 306 0.8× 220 1.1× 239 2.4× 20 2.3k
Walden Ai United States 22 1.3k 1.2× 382 0.8× 426 1.1× 442 2.2× 47 0.5× 27 1.9k
Janine Arts Netherlands 23 1.1k 1.0× 251 0.5× 488 1.2× 143 0.7× 79 0.8× 44 1.7k
Deyong Jia China 21 777 0.8× 241 0.5× 389 1.0× 140 0.7× 49 0.5× 33 1.2k
Chun‐Ping Cui China 24 1.2k 1.2× 426 0.9× 338 0.9× 209 1.0× 210 2.1× 61 1.7k

Countries citing papers authored by Ling Gu

Since Specialization
Citations

This map shows the geographic impact of Ling Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Gu more than expected).

Fields of papers citing papers by Ling Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Gu. The network helps show where Ling Gu may publish in the future.

Co-authorship network of co-authors of Ling Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Gu. A scholar is included among the top collaborators of Ling Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Gu. Ling Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Yujiao, Yingyue Cui, Bingqing Lin, et al.. (2024). Hydrochlorothiazide disrupts DNA damage response to exacerbate skin photosensitivity. Ecotoxicology and Environmental Safety. 287. 117314–117314.
2.
Zhang, Siqi, Ling Gu, Jie Zhang, et al.. (2021). Automatic consecutive context perceived transformer GAN for serial sectioning image blind inpainting. Computers in Biology and Medicine. 136. 104751–104751. 8 indexed citations
3.
Li, Yuanyuan, Chuan Zuo, & Ling Gu. (2021). Characterization of a novel glucocorticoid-resistant human B-cell acute lymphoblastic leukemia cell line, with AMPK, mTOR and fatty acid synthesis pathway inhibition. Cancer Cell International. 21(1). 623–623. 3 indexed citations
4.
Zhang, Shiping, Qian Gao, Ling Gu, et al.. (2021). Ophiopogonin B inhibits migration and invasion in non-small cell lung cancer cells through enhancing the interaction between Axin and β-catenin. Journal of Cancer. 12(20). 6274–6284. 14 indexed citations
5.
Li, Yuanyuan & Ling Gu. (2021). Establishment and characterization of HXWMF-1: the first mouse fibroblastic tumor cell line derived from leukemia-associated fibroblasts. Cancer Cell International. 21(1). 177–177. 5 indexed citations
6.
Zhang, Siqi, Lei Wang, Jie Zhang, et al.. (2020). Consecutive Context Perceive Generative Adversarial Networks for Serial Sections Inpainting. IEEE Access. 8. 190417–190430. 4 indexed citations
7.
Wei, Xiaoying, et al.. (2020). T lymphocytes related biomarkers for predicting immunotherapy efficacy in non‑small cell lung cancer (Review). Oncology Letters. 21(2). 89–89. 7 indexed citations
8.
Zhu, Yiping, Rong Yang, Ju Gao, et al.. (2019). Establishment and characterization of a novel childhood acute lymphoblastic leukemia cell line, HXEX-ALL1, with chromosome 9p and 17p deletions. Cancer Cell International. 19(1). 113–113. 4 indexed citations
9.
Zhang, Jie, Jing Cong, Jie Yang, et al.. (2018). Morphologic and morphometric study on microvasculature of developing mouse kidneys. American Journal of Physiology-Renal Physiology. 315(4). F852–F860. 5 indexed citations
10.
Zhang, Ping, Ling Gu, Jing Cong, et al.. (2018). Morphology of the initial nephron-collecting duct connection in mice using computerized 3D tracing and electron microscopy. Biochemical and Biophysical Research Communications. 509(1). 114–118. 9 indexed citations
12.
Wu, Xiaoliang, Zhongwen Li, Ling Gu, et al.. (2017). NORAD Expression Is Associated with Adverse Prognosis in Esophageal Squamous Cell Carcinoma. Oncology Research and Treatment. 40(6). 370–374. 40 indexed citations
14.
Gu, Ling, Liping Xie, Chuan Zuo, et al.. (2015). Targeting mTOR/p70S6K/glycolysis signaling pathway restores glucocorticoid sensitivity to 4E-BP1 null Burkitt Lymphoma. BMC Cancer. 15(1). 529–529. 24 indexed citations
17.
Murray, Stephen A., Hongwu Zheng, Ling Gu, & Zhi‐Xiong Jim Xiao. (2003). IGF-1 activates p21 to inhibit UV-induced cell death. Oncogene. 22(11). 1703–1711. 28 indexed citations
18.
Janocko, Laura, Kathryn Brown, Charles A. Smith, et al.. (2001). Distinctive patterns of Her‐2/neu, c‐myc, and cyclin D1 gene amplification by fluorescence in situ hybridization in primary human breast cancers. Cytometry. 46(3). 136–149. 37 indexed citations
19.
Smith, C.A., Alessio Pollice, Ling Gu, et al.. (2000). Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.. PubMed. 6(1). 112–26. 41 indexed citations
20.
Shackney, Stanley E., Alessio Pollice, C.A. Smith, et al.. (1998). Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients.. PubMed. 4(4). 913–28. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026